Deprescribing in the chronic terminal patient: statins as an example for reflection
Keywords:
-Abstract
-Downloads
References
Woodward MC. Deprescribing: Achieving Better Health Outcomes for Older People through Reducing Medications. Journal of Pharmacy Practice and Research. 2003; 33:323-328.
Le Couteur D, Gnjidic D, McLachlan A. Deprescribing. Australian Prescriber. 2011; 34:182-185.
Thompson W, Farrell B. Deprescribing: what is it and what does the evidence tell us? Can J Hosp Pharm. 2013;66:201-202.
Scott IA, Hilmer SN, Reeve E, Potter K, Le Courteur D, Rigby D et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA. 2015; 175:827-834.
Gavilan-Moral E, Villafaina-Barroso A, Jimenez-de Gracia L, Gomez Santana MC. Ancianos frágiles polimedicados: ¿es la deprescripción de medicamentos la salida? Rev Esp Geriatr Gerontol. 2012; 47:162-167.
Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80:1254-1268.
Rodriguez Perez A, Alfaro Lara ER, Nieto Martin MD, Ruiz Cantero A, Santos Ramos B. Deprescribing in patients with multimorbidity: a necessary process. Eur Intern Med. 2015; 26:e18-19.
Kutner JS, Blatchford PJ, Taylor DH, Ritchie CS, Bull JH, Fairclough DL et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: A randomized clinical trial. JAMA Intern Med. 2015;175:691-700.
Ministerio de Sanidad, Servicios Sociales e Igualdad [consultado 26 Septiembre 2017]. Disponible en: htmhttp://www.msssi.gob.es/profesionales/nomenclator.do.
Servicio Murciano de Salud [consultado 26 Septiembre 2017]. Disponible http://www.murciasalud.es/gftb.php? idsec=474&opt=ficha1&cod=C10AA08&area=1.
Additional Files
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
